BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients

BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients

AimA prospective dose escalation trial was developed to evaluate the maximum tolerated dose of stereotactic body radiotherapy (SABRT) to primary breast cancer in stage IV disease. The aim of the present report was to describe safety and outcome of the first dose level cohort of patients.Material and...

Full description

Bibliographic Details
Main Authors: Edy Ippolito, Sonia Silipigni, Francesco Pantano, Paolo Matteucci, Sofia Carrafiello, Maristella Marrocco, Rita Alaimo, Vincenzo Palumbo, Michele Fiore, Paolo Orsaria, Rolando Maria D’Angelillo, Vittorio Altomare, Giuseppe Tonini, Sara Ramella
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Oncology
Subjects:
stereotactic radiation (SBRT)
breast cancer
metastatic patients
safety
outcome
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1062355/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1062355/full

Similar Items